Solana (HSDT) vs RiverNorth/DoubleLine Strategic Opportunity Fund (OPP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
RiverNorth/DoubleLine Strategic Opportunity Fund is the larger company by market cap ($172.4 million vs $165.4 million), about 1.0 times the size. On valuation, Solana trades at a lower trailing P/E (0.0x vs 9.1x for RiverNorth/DoubleLine Strategic Opportunity Fund).
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | HSDT | OPP |
|---|---|---|
| Share price | $2.54 | $6.90 |
| Market cap | $165.37M | $172.43M |
| 1-day change | -4.51% | -0.72% |
| YTD return | -12.11% | — |
| 1-year return | -86.01% | — |
| 5-year return | -100.00% | — |
| P/E ratio (TTM) | 0.05 | 9.08 |
| EPS (TTM) | $53.74 | $0.76 |
| Dividend yield | 0.00% | 15.83% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.97 | $8.53 |
| 52-week low | $1.19 | $6.82 |
| Distance from 52-week high | -85.87% | -19.11% |
| Analyst consensus | none | — |
| Avg. price target upside | +37.80% | — |
| Average volume | 349.94K | 98.54K |
| Shares outstanding | 65.10M | 24.99M |
| Employees | 21 | — |
| Sector | Health Care | Finance |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance/Investors Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RiverNorth/DoubleLine Strategic Opportunity Fund trades at a higher earnings multiple (9.1x vs 0.0x trailing P/E).
- RiverNorth/DoubleLine Strategic Opportunity Fund offers a meaningfully higher dividend yield (15.83% vs 0.00%).
- The two companies sit in different sectors: Solana in Health Care and RiverNorth/DoubleLine Strategic Opportunity Fund in Finance.
About Solana
HSDT stock →Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 21 employees
About RiverNorth/DoubleLine Strategic Opportunity Fund
OPP stock →RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. is a closed ended fixed income mutual fund launched and managed by RiverNorth Capital Management, LLC.
Finance · Finance/Investors Services
HSDT vs OPP FAQ
Which is bigger, Solana or RiverNorth/DoubleLine Strategic Opportunity Fund?
RiverNorth/DoubleLine Strategic Opportunity Fund (OPP) is larger, with a market capitalization of $172.43M compared with $165.37M for Solana (HSDT).
Which has the lower P/E ratio, HSDT or OPP?
HSDT has the lower trailing P/E at 0.0, versus 9.1 for OPP. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Solana or RiverNorth/DoubleLine Strategic Opportunity Fund?
RiverNorth/DoubleLine Strategic Opportunity Fund pays a dividend yielding 15.83%, while Solana does not currently pay a regular dividend.
Are Solana and RiverNorth/DoubleLine Strategic Opportunity Fund in the same industry?
No. Solana is in the Health Care sector, while RiverNorth/DoubleLine Strategic Opportunity Fund is in Finance.